Hims & Hers Stocks Sinks Despite Huge Revenue Growth. Is This a Buying Opportunity in the Stock?
Although the telemedicine company displayed blistering growth and issued robust guidance, shares of Hims & Hers (NYSE: HIMS) ...
Why Hims & Hers Health Stock Sank This Week
Shares of Hims & Hers Health (NYSE: HIMS) sank 10.5% this week, according to data from S&P Global Market Intelligence. The ...
The Globe’s stars and dogs for the week
But with bitcoin plunging to less than US$79,000 at one point this week – down from a peak of more than US$109,000 in January ...
Zacks.com on MSN18h
Finding Opportunities in This Shifting Market
There are cracks forming in the façade of the stock market right now. The best and brightest stocks of the last few months ...
Eli Lilly takes aim at weight-loss drug copies with new ad campaign
Eli Lilly launched an ad campaign on Friday, cautioning patients against the risks of unapproved weight-loss drugs in its ...
BUZZ Investing: Markets Navigate Policy Shifts
The BUZZ NextGen AI US Sentiment Leaders Index returned 2.66% during the month of January, compared to a return of 2.78% for the S&P 500 Index during the same period.
Mounjaro Maker Eli Lilly Swipes at Unapproved GLP-1 Rivals in Oscars Ad
Eli Lilly's bet on the Oscars shows the GLP-1 ad wars are heating up. - Eli Lilly. At the 2024 Academy Awards, Eli Lilly, the ...
Jim Cramer Discusses These 12 Stocks & Says Late Selloffs Are Deliberate
When asked whether we’ll ever find out who was behind the selloff, the CNBC TV show host stated: “Well no, and you never will ...